Integrin-Targeted AmpRGD Sunitinib Liposomes as Integrated Antiangiogenic Tools

Nanomedicine: Nanotechnology, Biology, and Medicine - Netherlands
doi 10.1016/j.nano.2019.02.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cell-Targeted C(AmpRGD)-Sunitinib Molecular Conjugates Impair Tumor Growth of Melanoma

Cancer Letters
Cancer ResearchOncology
2019English

Aortic Dissection During Antiangiogenic Therapy With Sunitinib. A Case Report

Sao Paulo Medical Journal
Medicine
2014English

Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

v 3 Integrin-Dependent Antiangiogenic Activity of Resveratrol Stereoisomers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Ageing-Related Responses to Antiangiogenic Effects of Sunitinib in Atherosclerosis-Prone Mice

Mechanisms of Ageing and Development
AgingDevelopmental Biology
2014English

Molecular Targeted Viral Nanoparticles as Tools for Imaging Cancer

Methods in Molecular Biology
GeneticsMolecular Biology
2013English

Integrin Targeted Delivery of Gene Therapeutics

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2011English

Echogenic Liposomes for Molecular Targeted Therapeutic Delivery

Journal of the Acoustical Society of America
AcousticsUltrasonicsArtsHumanities
2008English

Integrated Collaborative Tools

International Review of Research in Open and Distance Learning
E-learningEducation
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy